The chylomicronemia syndrome is characterized by severe hypertriglyceridemia and fasting
chylomicronemia and predisposes affected individuals to acute pancreatitis. When due to …

Kidney transplantation is the gold-standard treatment for many patients with end-stage renal
disease. Renal transplant recipients (RTRs) remain at an increased risk of fatal and non …

Post-transplant dyslipidemia is highly prevalent and presents unique management
challenges to the clinician. The two major outcomes to consider with post-transplant …

Patients with kidney diseases continue to experience significant cardiovascular disease
(CVD) morbidity and mortality. Although there are many important risk factors playing a role …

During the past years, targeted therapies for cancer have been developed using drugs that
have significant metabolic consequences. Among them, the mammalian target of rapamycin …

Cyclosporin A (CsA), tacrolimus and rapamycin are immunosuppressive agents (IAs)
associated with insulin resistance and dyslipidemia, although their molecular effects on lipid …

Monitoring metabolic adaptation to chronic kidney disease (CKD) early in the time course of
the disease is challenging. As a non-invasive technique, analysis of exhaled breath profiles …

Atherosclerotic cardiovascular disease (ASCVD) morbidity and mortality are decreasing in
high-income countries, but ASCVD remains the leading cause of morbidity and mortality in …

Among other factors, sophistication of immunosuppressive (IS) regimen accounts for the
remarkable success attained in the short-and medium-term solid organ transplant (SOT) …

Background Hypercholesterolaemia is common in patients after cardiac transplantation.
Monoclonal antibodies that inhibit proprotein convertase subtilisin-kexin type 9 (PCSK9) …